82 / 1674
Prosigna (PAM50)
(NanoString Technology, USA )
MOLECULAR SUBTYPES
(LumA, LumB, HER2, Basal)
FFPE SAMPLES
50 GENES
LOCAL TEST
(providing dedicated equipment and learning phase)
RECURRENCE (10 years)
RISK OF RELAPSE (ROR)
(node status needed)
LOW RISK
+ HT / NO CHEMOTHERAPY
INTERMEDIATE
HIGH RISK
+ HT / + CHEMOTHERAPY